Health ❯ Cancer ❯ Cancer Treatment

Immunotherapy

Checkpoint Inhibitors Personalized Medicine T Cell Therapy Immune Checkpoint Inhibitors Dietary Interventions Cancer Immunotherapy Cancer Cells T Cells Next-Generation Therapies Circadian Rhythms CD27 Receptors Chronotherapy CD8+ T Cells Metastasis Prevention Dendritic Cells Thymus and Cancer Clinical Trials Novel Therapeutics Chimeric Antigen Receptor Therapy Regulatory Mechanisms Therapeutic Strategies Sucralose Effects Antibody Therapy mRNA Therapies Regulatory T Cells in Cancer Keytruda mRNA-based Cancer Vaccines Genetically Engineered Therapies Patient Experiences Peptide Therapies

FDA Issues Second Rejection of Replimune’s RP1 Melanoma Therapy

The decision signals the agency’s demand for stronger, more consistent evidence than Replimune’s single‑arm data.

Southampton Team Engineers Four-Pronged Antibodies to Boost T‑Cell Activation in Preclinical Cancer Tests

Immunotherapy Before 3 p.m. Linked to Longer Survival in Small Cell Lung Cancer

Unified Model Reveals How Antimicrobial Peptides Form Transient Pores to Kill Bacteria

Studies Show Lymph Nodes Sustain Stem-Like T Cells That Power Cancer Immunotherapy

Eye-Health Nutrient Zeaxanthin Boosts T Cells in Preclinical Cancer Study

T Cells Convert Sugar Into Lipid Rafts to Amplify Tumor-Fighting Signals

Researchers Plan Trials to Counteract Sucralose’s Impairment of Cancer Immunotherapy

Coordinated Loss of the Y Chromosome in Tumors Linked to Poor Cancer Survival

Bristol Myers Squibb and BioNTech partner on $11 billion bispecific antibody cancer drug

UCLA Study Finds Antidepressants Boost Immune Response Against Cancer